Global Dextrose Injection Market Size, Share, Trends, Market Segmentation By Product Type, By Application, By End User & by Region with Forecast 2017-2030

Global Dextrose Injection Market Overview

Dextrose Injection, USP has value as a source of water and calories and is capable of inducing diuresis depending on the clinical condition of the patient. Dextrose Injections USP are sterile, nonpyrogenic and contain no bacteriostatic or antimicrobial agents. These products are intended for intravenous administration. These intravenous solutions are indicated for use in adults and pediatric patients as sources of calories and water for hydration. Dosage of dextrose injection is dependent upon the age, weight, and clinical condition of the patient as well as laboratory determinations. Weifang Shengtai supplied Kelun Pharmaceutical which has grown into a pharmaceutical group with 16 subsidiaries with 10 thousand tons of dextrose monohydrate injection grade.

Goldstein Market Intelligence analyst forecast the dextrose injection market size is set to register the growing CAGR of 5.2% over the forecast years 2017-2030. Availability in variety of dosage forms and demand of dextrose injection to treat nutritional deficiencies are the key drivers of the dextrose injection market.

Global Dextrose Injection Market Segmentation

By Product Type

• 5% Dextrose Injection
• 10% Dextrose Injection
• 50% Dextrose Injection
• 70% Dextrose Injection
• Other

By Application

• Sports
• First-Aid Treatment
• Trophotherapy
• Other

By End User

• Hospital
• Medical Center
• Others

Intended Audience

• Dextrose injection Suppliers
• Dextrose injection manufacturers
• Research and Development (R&D) Companies
• Medical Research Laboratories
• Diagnostic centers
• Academic Medical Institutes and Universities

Based on Geography

• North America (U.S. & Canada) Dextrose injection Market {Market Share (%), Market Size (USD Billion)}
• Latin America (Brazil, Mexico, Argentina & Rest of Latin America) Dextrose injection Market {Market Share (%), Market Size (USD Billion)}
• Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) Dextrose injection Market {Market Share (%), Market Size (USD Billion)}
• Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) Dextrose injection Market {Market Share (%), Market Size (USD Billion)}
• Middle East & Africa (GCC, South Africa, North Africa, RoMEA) Dextrose injection Market {Market Share (%), Market Size (USD Billion)}

Based on product type, 5% dextrose injection held the largest share valued 42% in the global dextrose injection market owing to the increasing usage in clinical pharmacology where dextrose and sodium chloride injection, USP has value as a source of water, electrolytes, and calories and is capable of inducing diuresis depending on the clinical condition of the patient while 10% dextrose is growing at the substantial rate owing to fastest scene times and the fastest recovery times in brain damage conditions.

Dextrose Injection Market  Analysis

According to our global market study on the basis of extensive primary and secondary research: “One trend is the availability of single dose containers of hydrous dextrose for intravenous administration with no antimicrobial agents with variable composition, osmolarity, pH and caloric content. For instance, VIAFLEX plastic container by Baxter is fabricated from a specially formulated polyvinyl chloride and indicated as the source of water and calories.”

Based on geography, APAC held the dominant position in global dextrose injection market with the market share of 40% in 2017 owing to presence of leading producer like Weifang Shengtai of pharmaceutical injection-grade glucose in China, which has about 40% of the market and is one of the only 3 licensed manufacturers in China of injection grade dextrose monohydrate. North America is the emerging market followed by Europe owing to the demand of dextrose injection to treat the conditions like replenishment of lost fluids and carbohydrates.

Market Growth Drivers and Market Restraints 

According to the report, major driving factor is the increasing cases of hypoglycemia condition characterized by an abnormally low level of blood sugar and is commonly associated with the treatment of diabetes. Emergency Department (ED) visit rates for hypoglycemia were highest among adults with diabetes aged 75 years or older, almost 3 times as high as the group aged 45–64 years with the lowest rates.   

Further, the report states the biggest challenge is the risk of air embolism and hypersensitivity/infusion reaction including anaphylactic/anaphylactoid reactions that have been reported with 5% dextrose injection and 10% dextrose injection.

Covered In This Global Dextrose Injection Market Report         

The report covers the present ground scenario and the future growth prospects of the dextrose injection market for 2017-2030 along with the data of end user medical facilities worldwide. We calculated the market size and revenue share on the basis of revenue generated from major players across the globe. The Dextrose injection Market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players. The report also includes micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Global Dextrose injection Market Outlook 2017-2030, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global Dextrose injection Market. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global Dextrose injection Market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.

Key Market Players

Our global Dextrose injection Market report comprises of the following companies as the key players:

• Pfizer
•  Amphastar
•  ChanGee
•  HAIXIN
•  Seqirus
•  Baxter
•  Shandong Qidu Pharmaceutical
•  Sanctus Drugs & Pharmaceuticals Pvt
•  Mountainside Medical
•  Shaanxi Torch Biotechnology
•  Hospira, B Braun.

 The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key questions answered in this Dextrose Injection Market Report

• What is the total market size by 2030 and what would be the expected growth rate of market?
• What is the revenue of total market in 2016-17 and what would be the expected demand over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.